Skip to content

iLet ACE Pump

by Beta Bionics, Inc. 2 variants

510(k) K252770

iLet ACE Pump is a medical device (FDA Class II; FDA product code QFG, Alternate Controller Enabled Insulin Infusion Pump) made by Beta Bionics, Inc., cleared under FDA 510(k) K252770 on 29 Sep 2025, active as of 22 Oct 2026. 2 FDA recalls are linked to it.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

2 ongoing

This device is named in the recall

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Special NumberK252770 Date29 Sep 2025ClearedStatusActive

Official records

From the FDA record

Received by the FDA
2 Sep 2025
FDA decision
29 Sep 2025 (Substantially Equivalent)
FDA review time
27 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K252770 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Recalls

2 recalls · 2 ongoing · FDA

    • Ongoing Z-1996-2026 FDA Class II initiated 12 Mar 2026

    insulin pump software versions 1.4.2, and 1.4.3 issue with Dexcom Continuous Glucose Monitoring (CGM) G7 sensor may result in delayed CGM reading then switch to non-CGM dosing, leading to only basal/requested meal doses provided, no correction doses/insulin reductions/suspensions for high/low glucose unless blood glucose entered for sensor life or replacement. Potential health risks to users include severe hyperglycemia with and without DKA and severe hypoglycemia.

    • Ongoing Z-2513-2026 FDA Class II initiated 23 Sep 2025

    The reason for the recall is: it was found in version 3.3.6 of the iLet ACE Pump firmware and all previous releases that a screen unlock failure could occur when the user successfully slides the unlock slider on the Lock Screen, no screen transition occurs, and the user remains on the Lock Screen. Because the user cannot exit the Lock Screen, the user is unable to perform a cartridge change or meal announcement. If this occurs and therapy is in progress, therapy will continue normally until the insulin cartridge is depleted. The user will be unable to perform a cartridge change or a meal announcement and will be stuck on the screen until the battery fully drains. This can lead to hyperglycemia.

Timeline

3 dated events

  1. Recall initiated FDA recalls Z-2513-2026
  2. Cleared FDA 510(k) K252770
  3. Recall initiated FDA recalls Z-1996-2026

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
QFG
Device class
Class II
Regulation
21 CFR Part 880.5730
Advisory committee
Clinical Chemistry
FDA decision
SESE Substantially Equivalent

Similar devices

Other devices filed under FDA product code QFG (Alternate Controller Enabled Insulin Infusion Pump).

Other devices from Beta Bionics, Inc.

See all devices from Beta Bionics, Inc. →